Company / Shareholders' Equity
GRI Bio, Inc. Shareholders' Equity History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$1.5M
FY2021
5-year range
-$1.5M / -$1.5M
FY2021-FY2021
Trend
-
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$1M in FY2021.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$1.5M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026